The COVID Boom: CBER Receives More INDs in One Quarter Than The Previous 30 Combined
Source : 'The Pink Sheet'
The coronavirus pandemic attracted a historic tsunami of investigational work to the US Food and Drug Administration’s Center for Biologics Evaluation and Research, which may affect its operations even after...
Has UK Got Vaccine Strategy Right Again With Choice For Under 30s?
Source : 'The Pink Sheet'
The UK has achieved one of the fastest and most successful COVID-19 vaccination programs anywhere in the world so far, thanks to its early procurement deals with manufacturers, and a...
Coronavirus Notebook: EMA Probes Janssen Vaccine Blood Clot Reports, UK Advises 12-Week Dosing Gap For Moderna
Source : 'The Pink Sheet'
It's been a big week for safety updates on the coronavirus vaccine front.
After UK and EU regulators warned of the risk of unusual blood clots combined with low platelet...
Pink Sheet Podcast: EUA’s Impact On US FDA, March-In Rights, CBER And Real-Time Oncology Review
Source : 'The Pink Sheet'
Pink Sheet senior writers Derrick Gingery and Sarah Karlin-Smith and Executive Editor Nielsen Hobbs discuss the impact of the US Food and Drug Administration’s experience with the emergency use authorization...
